Detalhe da pesquisa
1.
Discontinuation of the renin-angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes.
Ther Adv Hematol
; 12: 2040620720958299, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33489062
2.
Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De-Novo, Particularly Low-Grade Myelodysplastic Syndromes.
Cytometry B Clin Cytom
; 96(1): 73-82, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334347
3.
Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis-A Case Report.
Case Rep Hematol
; 2018: 2525070, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30524760
4.
mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia.
Leuk Res
; 53: 65-73, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28038356
5.
Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.
Pathol Res Pract
; 212(12): 1194-1198, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28340951
6.
BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.
Leuk Lymphoma
; 57(9): 2199-203, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27442703